ITGA2B and diabetes mellitus: Our study suggests that use of GP IIb/IIIa inhibitor is the only independent good prognostic indicator, while history of diabetes is the only independent poor prognostic indicator of the composite endpoint of cardiovascular mortality, ACS or TLR.